Cordys Analytics is proud to announce that it has been awarded a prestigious Eurostars grant. This grant, aimed at fostering innovation and collaboration among small and medium-sized enterprises across Europe, will significantly enhance Cordys Analytics’ research and development capabilities. The €800,000 funding will be directed towards developing an AI-powered platform

UTRECHT, Netherlands – Utrecht Health Seed Fund and imec.istart invest 300K+ euros in Ascenscia.   Ascenscia is an emerging tech startup in laboratory automation. Their product comprises a highly specialized voice assistant for scientific laboratories. It understands scientific terminologies and workflows efficiently and enables scientists to communicate with other lab

Dear Founder, We are excited to announce that the applications for the 4th edition of the Academic Startup Competition are open! The Academic Startup Competition (ASC) is a joint initiative of Techleap, UNL, NFU, NAE, UTwente, VU and EZK. The competition offers a curated batch of 20 selected academic startups

A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies. Below the press relaese; • Phlox Therapeutics raises additional seed funding to develop RNA therapies for genetic laminopathies • Funds will advance the company’s lead program into preclinical

The Utrecht Health Seed Fund is happy to announce the start of its new Investment Manager: Timo Koopmans. Timo holds a PhD in medicinal chemistry from Utrecht University and as a startup founder himself, understands the challenges young companies face. Furthermore he has experience at a management & innovation consultancy

Before we knew, we’re celebrating Utrecht Health Seed Fund’s first anniversary! And what a year it has been. We can’t express how proud we are of our exceptional portfolio companies and the talented entrepreneurs and scientists driving these ventures: – TargED Biopharmaceuticals is developing a next generation clot-busting drug with

TargED Biopharmaceuticals, a biotech spin-off of the University Medical Center Utrecht, today announced the appointment of Ludo Haazen as Chief Medical Officer (CMO). Kristof Vercruysse, CEO of TargED commented: “We are delighted that Ludo is joining our team as CMO. In Ludo, we found the ideal candidate to support the

We proudly announce UHSF’s second investment, in Moveshelf, together with Locapes Investment Fund. Moveshelf is a digital health company with a unique platform for clinical movement analysis. We look forward to working with their talented team! Please find the press release below: March 2nd, 2021, Utrecht, The Netherlands   Moveshelf, a

Congratulations to the team of our portfolio company TargED Biopharmaceuticals, as they have been awarded a Take-Off 2 grant from NWO (the Dutch National Science Organization)!

The Utrecht Health Seed Fund (UHSF) officially launched at the end of March. Over the next three years, it’ll be looking to invest in promising start-ups based in the province of Utrecht and working in the field of Life Sciences & Health (LS&H). Jaap de Bruin (UHSF Fund Manager) explains the reasons for setting up the UHSF, “Utrecht is